We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$12.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Real Estate 18.02%
3 Energy 12.43%
4 Materials 10.7%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTEM
276
DELISTED
Molecular Templates, Inc.
MTEM
$238K 0.12%
1,452
-198
-12% -$35.2K
NGM
277
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$237K 0.12%
14,880
-2,033
-12% -$37.1K
DVAX
278
DELISTED
Dynavax Technologies
DVAX
$233K 0.12%
53,984
-7,347
-12% -$52.4K
ARVN icon
279
Arvinas
ARVN
$530M
$232K 0.12%
9,826
-1,336
-12% -$38.7K
AMRS
280
DELISTED
Amyris Inc.
AMRS
$231K 0.12%
79,234
-10,811
-12% -$39.6K
SCM icon
281
Stellus Capital Investment Corp
SCM
$205M
$230K 0.12%
26,455
-9,803
-27% -$79.8K
PHAT icon
282
Phathom Pharmaceuticals
PHAT
$928M
$229K 0.12%
6,242
-834
-12% -$28.9K
OYST
283
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$226K 0.12%
10,712
-1,476
-12% -$34.5K
HRZN icon
284
Horizon Technology Finance
HRZN
$294M
$222K 0.12%
18,106
-7,199
-28% -$85.2K
QTTB icon
285
Q32 Bio
QTTB
$435M
$222K 0.12%
1,153
-157
-12% -$35.2K
KNSA icon
286
Kiniksa Pharmaceuticals
KNSA
$6.31B
$219K 0.11%
14,317
-1,957
-12% -$36.7K
MVC
287
DELISTED
MVC Capital, Inc.
MVC
$214K 0.11%
+27,393
New +$199K
GLAD icon
288
Gladstone Capital
GLAD
$427M
$213K 0.11%
14,389
-4,415
-23% -$65.5K
VSTM icon
289
Verastem
VSTM
$528M
$212K 0.11%
14,593
-1,991
-12% -$33K
OCSI
290
DELISTED
Oaktree Strategic Income Corporation
OCSI
$211K 0.11%
32,388
-12,501
-28% -$81K
MRCC
291
DELISTED
Monroe Capital Corp
MRCC
$210K 0.11%
30,723
-6,162
-17% -$42.1K
PNNT
292
Pennant Park Investment Corp
PNNT
$220M
$209K 0.11%
65,668
-16,100
-20% -$53.9K
SAR icon
293
Saratoga Investment
SAR
$309M
$209K 0.11%
12,477
-4,934
-28% -$84.1K
CSWC icon
294
Capital Southwest
CSWC
$1.47B
$208K 0.11%
14,799
-32,485
-69% -$457K
FDUS icon
295
Fidus Investment
FDUS
$759M
$208K 0.11%
21,084
-6,285
-23% -$60.5K
CALA
296
DELISTED
Calithera Biosciences, Inc
CALA
$208K 0.11%
3,016
-411
-12% -$35.9K
SUNS
297
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$205K 0.11%
16,300
-2,522
-13% -$32.9K
OXSQ icon
298
Oxford Square Capital
OXSQ
$150M
$202K 0.11%
81,968
-19,276
-19% -$51.8K
PRVL
299
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$201K 0.11%
19,773
-2,687
-12% -$36K
WHF icon
300
WhiteHorse Finance
WHF
$138M
$197K 0.1%
20,169
-9,753
-33% -$100K

Similar funds

Virtus ETF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Virtus ETF Advisers held 450 positions worth $191M, down 9.7% from $211M the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Virtus ETF Advisers withdrew a net $12.4M in Q3 2020, closing 125 positions and reducing 215 holdings. Its most notable exit was CNX Midstream Partners LP, an estimated $744K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Oxford Lane Capital worth $1.03M.

  • Virtus ETF Advisers's largest Q3 2020 buy was Oxford Lane Capital: 46,671 shares worth $1.03M.
  • Virtus ETF Advisers added most to Brookfield Infrastructure in Q3 2020, an estimated $1.03M increase.
  • Virtus ETF Advisers's biggest Q3 2020 reduction was Delek Logistics, cutting an estimated $2.13M.
  • Virtus ETF Advisers fully exited CNX Midstream Partners LP in Q3 2020, selling an estimated $744K.
  • Virtus ETF Advisers's ten largest holdings make up 8% of its $191M portfolio in Q3 2020.
  • Virtus ETF Advisers opened 8 new positions and closed 125 in Q3 2020.
  • Virtus ETF Advisers's portfolio value fell 9.7% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.